Sidoti Csr Analysts Lift Earnings Estimates for Balchem

Balchem Co. (NASDAQ:BCPC - Free Report) - Equities research analysts at Sidoti Csr raised their Q1 2025 earnings per share (EPS) estimates for Balchem in a research note issued to investors on Tuesday, February 25th. Sidoti Csr analyst D. Harriman now anticipates that the basic materials company will post earnings of $1.25 per share for the quarter, up from their prior forecast of $1.19. The consensus estimate for Balchem's current full-year earnings is $4.64 per share. Sidoti Csr also issued estimates for Balchem's Q2 2025 earnings at $1.28 EPS, Q3 2025 earnings at $1.30 EPS, Q4 2025 earnings at $1.27 EPS, FY2025 earnings at $5.10 EPS, Q1 2026 earnings at $1.33 EPS, Q2 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.38 EPS, Q4 2026 earnings at $1.33 EPS and FY2026 earnings at $5.40 EPS.

Other research analysts have also issued reports about the company. StockNews.com lowered Balchem from a "buy" rating to a "hold" rating in a report on Tuesday. HC Wainwright reissued a "buy" rating and issued a $190.00 price target on shares of Balchem in a research note on Monday, February 24th. Finally, Sidoti raised Balchem to a "hold" rating in a research note on Tuesday.

Balchem Price Performance

NASDAQ:BCPC traded up $2.03 during mid-day trading on Wednesday, reaching $174.03. 134,481 shares of the stock were exchanged, compared to its average volume of 131,741. The business has a fifty day moving average price of $162.41 and a 200 day moving average price of $169.56. The firm has a market capitalization of $5.66 billion, a PE ratio of 44.28, a PEG ratio of 4.41 and a beta of 0.69. Balchem has a 1-year low of $137.69 and a 1-year high of $186.03. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19.

Balchem (NASDAQ:BCPC - Get Free Report) last released its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The firm had revenue of $240.00 million for the quarter, compared to analyst estimates of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%.

Balchem Increases Dividend

The business also recently declared an annual dividend, which was paid on Friday, January 17th. Investors of record on Thursday, December 26th were paid a $0.87 dividend. The ex-dividend date was Thursday, December 26th. This represents a yield of 0.4%. This is a boost from Balchem's previous annual dividend of $0.79. Balchem's dividend payout ratio (DPR) is currently 22.14%.

Hedge Funds Weigh In On Balchem

A number of institutional investors have recently bought and sold shares of the stock. Quadrant Capital Group LLC increased its stake in Balchem by 8.2% in the 4th quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company's stock worth $161,000 after purchasing an additional 75 shares in the last quarter. Covestor Ltd grew its stake in Balchem by 93.8% during the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after acquiring an additional 76 shares in the last quarter. Arizona State Retirement System grew its stake in Balchem by 0.8% during the 4th quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock valued at $1,534,000 after acquiring an additional 77 shares in the last quarter. Vident Advisory LLC grew its stake in Balchem by 6.0% during the 4th quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock valued at $232,000 after acquiring an additional 80 shares in the last quarter. Finally, Mackenzie Financial Corp grew its stake in Balchem by 2.2% during the 4th quarter. Mackenzie Financial Corp now owns 3,840 shares of the basic materials company's stock valued at $626,000 after acquiring an additional 84 shares in the last quarter. Hedge funds and other institutional investors own 87.91% of the company's stock.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.